Tracer library / [18F]T807
Structure of Flortaucipir (unlabelled parent compound, from PubChem)
Unlabelled parent compoundPubChem CID 71059746

[18F]T807

Also written as [18F]AV-1451; [18F]AV1451; [18F]Flortaucipir; [18F]T807; [F-18]AV-1451; [F-18]AV1451; [F-18]Flortaucipir
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
—
Stage
Approved
Syntheses indexed
7

What it is

Compound class
Radiolabelled carbazole/pyridoindole derivative (tau-binding small molecule)
Target / mechanism
Aggregated tau protein (paired helical filaments) FDA label NDA212123
Clinical application
PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles in adults being evaluated for Alzheimer's disease FDA label NDA212123
Theranostic pair
—

Regulatory status

FDA
2020, Tauvid, Avid Radiopharmaceuticals (Eli Lilly) FDA (Drugs@FDA/openFDA): NDA212123, approved 2020-05-28
EMA (centralised)
2024, Tauvid, Eli Lilly EMA medicines register export (2026-09-09): EMEA/H/C/006064, 'Authorised', authorised 22 Aug 2024
Other approvals
—
Brand names
Tauvid

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
TRACERlab FX FN
GE HealthCare
fixed tubingHPLC+SPE14%
not corrected
98 ± 1%N-Boc-protected nitro-precursor
Huayi
29503848
2017 EJNMMI Radiopharm Chem
An optimized [18F]AV1451 synthesis using a TRACERLab FXFN module - 202 ± 57 mCi at end-of-synthesis (EOS) (14% based on starting [18F]fluoride)
TRACERlab FX FN
GE HealthCare
—HPLC+SPE14 ± 3%
not corrected
>95%tert-butyl…tert-butyl 7-(6-nitropyridin-3-yl)-5H-pyrido[4,3-b]indole-5-carboxylate (1b)
Huayi
24339014
2013 J Labelled Comp Radiopharm
GE Tracerlab™ FXFN radiosynthesis module - The uncorrected RCY of [18F]T807 was 14 ± 3% (n = 3)
TRACERlab FX FN
GE HealthCare
—HPLC+SPE2.4%
not corrected
—7-(6-nitropyridin-3-yl)-5H-pyrido[4,3-b]indo…7-(6-nitropyridin-3-yl)-5H-pyrido[4,3-b]indole (1a)
Huayi
24339014
2013 J Labelled Comp Radiopharm
GE Tracerlab™ FXFN radiosynthesis module - The uncorrected radiochemical yield was much lower (2.4%; n = 1)
Synthra RNplus—HPLC+SPE14.8-16.6%
not corrected
>99.9%AV162234234995
2021 Am J Nucl Med Mol Imaging
an automated radiosynthesis of [18F]Flortaucipir in a RNplus Research module - The final products were obtained in non-decay corrected radiochemical yields of 14.8-16.6% (n = 3) within total synthesis time of 55 min.
———27%
not corrected
>99%—31083778
2019 J Labelled Comp Radiopharm
synthesized and formulated using an automated radiosynthesis module - nondecay corrected radiochemical yields of 27% and 29% (relative [18 F]F- ), respectively
Manual synthesis
n/a
——5-10%
decay-corrected
—T807P26048805
2015 Bioorg Med Chem Lett
through manual synthesis with 5-10% decay corrected radiochemical yield in two steps - 5-10% decay corrected radiochemical yield in two steps
In-house / custom built
Laboratory
—HPLC+SPE20-30%
decay-corrected
—t-Boc-protected T807P26048805
2015 Bioorg Med Chem Lett
in a home-built automated [(18)F]radiosynthesis module with 20-30% decay corrected radiochemical yield in one step - 20-30% decay corrected radiochemical yield in one step

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807.
    2014 · Mol Imaging · Clinical study

Precursor

Common precursor
—
Suppliers seen in the literature
—
Cited suppliers in indexed syntheses
Huayi
Typical final purification
—

Need this precursor?We can point you to suppliers for [18F]T807, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]T807.

Get in touch

Notes

Added from reverse module search (stage 6); 12 article(s) with F-18.
Ask a question